Neuronal Death and Blood-brain Barrier Breakdown After Excitotoxic Injury Are Independent Processes

Overview

Journal J Neurosci

Specialty Neurology

Date 1999 Nov 13

PMID 10559390

Citations 21

Authors

Z L Chen

J A Indyk

T H Bugge

K W Kombrinck

J L Degen

S Strickland

Affiliations

Soon will be listed here.

Abstract

Neuronal damage in the CNS after excitotoxic injury is correlated with blood-brain barrier (BBB) breakdown. We have used a glutamate analog injection model and genetically altered mice to investigate the relationship between these two processes in the hippocampus. Our results show that BBB dysfunction occurs too late to initiate neurodegeneration. In addition, plasma infused directly into the hippocampus is not toxic and does not affect excitotoxin-induced neuronal death. To test plasma protein recruitment in neuronal degeneration, we used plasminogen-deficient (plg(-/-)) mice, which are resistant to excitotoxin-induced degeneration. Plasminogen is produced in the hippocampus and is also present at high levels in plasma, allowing us to determine the contribution of each source to cell death. Intrahippocampal delivery of plasminogen to plg(-/-) mice restored degeneration to wild-type levels, but intravenous delivery of plasminogen did not. Finally, although the neurons in plg(-/-) mice do not die after excitotoxin injection, BBB breakdown occurs to a similar extent as in wild-type mice, indicating that neuronal death is not necessary for BBB breakdown. These results indicate that excitotoxin-induced neuronal death and BBB breakdown are separable events in the hippocampus.

Citing Articles

Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders.

Blaylock R Surg Neurol Int. 2025; 16:26.

PMID: 39926461 PMC: 11799683. DOI: 10.25259/SNI_1114_2024.

Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis.

Plawinski L, Cras A, Hernandez Lopez J, de la Pena A, Van Der Heyden A, Belle C Int J Mol Sci. 2023; 24(2).

PMID: 36675082 PMC: 9860915. DOI: 10.3390/ijms24021571.

Ninjurin 1 dodecamer peptide containing the N-terminal adhesion motif (N-NAM) exerts proangiogenic effects in HUVECs and in the postischemic brain.

Kim S, Lee H, Seol S, Davaanyam D, Lee H, Lee J Sci Rep. 2020; 10(1):16656.

PMID: 33028854 PMC: 7542178. DOI: 10.1038/s41598-020-73340-5.

Brain-Derived Microparticles (BDMPs) Contribute to Neuroinflammation and Lactadherin Reduces BDMP Induced Neuroinflammation and Improves Outcome After Stroke.

Chen Z, Chopp M, Zacharek A, Li W, Venkat P, Wang F Front Immunol. 2020; 10:2747.

PMID: 31993045 PMC: 6968774. DOI: 10.3389/fimmu.2019.02747.

Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP.

San Miguel M, Martin K, Stone J, Johnstone D Biomolecules. 2019; 9(10).

PMID: 31590236 PMC: 6843129. DOI: 10.3390/biom9100564.

References

Duncan R, Todd N . Epilepsy and the blood-brain barrier. Br J Hosp Med. 1991; 45(1):32-4. View

Wang Y, Tsirka S, Strickland S, Stieg P, Soriano S, Lipton S . Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998; 4(2):228-31. DOI: 10.1038/nm0298-228. View

Bolton S, Perry V . Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp Neurol. 1999; 154(1):231-40. DOI: 10.1006/exnr.1998.6927. View

Chen Z, Strickland S . Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 1998; 91(7):917-25. DOI: 10.1016/s0092-8674(00)80483-3. View

Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M . Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol. 1998; 44(4):592-600. DOI: 10.1002/ana.410440404. View

Lipton S, Rosenberg P . Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330(9):613-22. DOI: 10.1056/NEJM199403033300907. View

Coyle J, Molliver M, Kuhar M . In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage. J Comp Neurol. 1978; 180(2):301-23. DOI: 10.1002/cne.901800208. View

Roelcke U, Radu E, von Ammon K, Hausmann O, Maguire R, Leenders K . Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET. J Neurol Sci. 1995; 132(1):20-7. DOI: 10.1016/0022-510x(95)00117-k. View

Lassmann H, Baran H, Petsche U, Kitz K, Sperk G, Hornykiewicz O . Ultrastructural analysis of rat brain tissue following systemic kainate administration. Adv Exp Med Biol. 1986; 203:223-30. DOI: 10.1007/978-1-4684-7971-3_17. View

10.

Janzer R, Raff M . Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987; 325(6101):253-7. DOI: 10.1038/325253a0. View

11.

Tsirka S, Rogove A, Bugge T, Degen J, Strickland S . An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci. 1997; 17(2):543-52. PMC: 6573220. View

12.

Steinhauser C, Gallo V . News on glutamate receptors in glial cells. Trends Neurosci. 1996; 19(8):339-45. DOI: 10.1016/0166-2236(96)10043-6. View

13.

Rapoport S, Thompson H . Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits. Science. 1973; 180(4089):971. DOI: 10.1126/science.180.4089.971. View

14.

Coyle J, Puttfarcken P . Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993; 262(5134):689-95. DOI: 10.1126/science.7901908. View

15.

Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R . Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994; 368(6470):419-24. DOI: 10.1038/368419a0. View

16.

Bugge T, Flick M, Daugherty C, Degen J . Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 1995; 9(7):794-807. DOI: 10.1101/gad.9.7.794. View

17.

Bugge T, Kombrinck K, Flick M, Daugherty C, Danton M, Degen J . Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 1996; 87(4):709-19. DOI: 10.1016/s0092-8674(00)81390-2. View

18.

Ikuta F, Yoshida Y, Ohama E, Oyanagi K, Takeda S, Yamazaki K . Revised pathophysiology on BBB damage: the edema as an ingeniously provided condition for cell motility and lesion repair. Acta Neuropathol Suppl. 1983; 8:103-10. DOI: 10.1007/978-3-642-68970-3_9. View

19.

Hassel B, Iversen E, Fonnum F . Neurotoxicity of albumin in vivo. Neurosci Lett. 1994; 167(1-2):29-32. DOI: 10.1016/0304-3940(94)91020-0. View

20.

Albayrak S, Zhao Q, Siesjo B, Smith M . Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury. Acta Neuropathol. 1997; 94(2):158-63. DOI: 10.1007/s004010050688. View